Alexander Abitbol

7PUBLICATIONS

21CO-AUTHORS

Proteins and peptidesMolecular targetsPacific Peoples sport and physical activityBehavioural epidemiologyGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 26, 2026

In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for Hypercholesterolemia.

|May 21, 2026

Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.

|Apr 29, 2026

Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age.

|Aug 04, 2025

Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials.

Ronnie Aronson, Alexander Abitbol, Harpreet S Bajaj

|Feb 27, 2025

What do the guidelines say about use of biosimilar insulin therapy? Simple practical considerations to guide clinicians in different patient subgroups-Sharing Canadian perspectives.

A Abitbol, L Chu

|Aug 08, 2024

Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: The Impact GLP-1 CKD study.

Lisa Chu, Ryan M Bradley, Pernille Auerbach

Pageof 2

Frequent Collaborators

L Chu

Ronnie Aronson

Harpreet S Bajaj

Alice Y Y Cheng

Stavroula Christopoulos

Stewart B Harris

Akshay B Jain

Ronald M Goldenberg

Brian A Smith

Marie Van der Wielen

Frequent Collaborators

L Chu

Ronnie Aronson

Harpreet S Bajaj

Alice Y Y Cheng